Owkin Doses First Patient in Phase I Trial of AI-Optimized Cancer Therapy OKN4395
What You Ought to Know: – Owkin, an AI-powered biotech firm, as we speak introduced the ...
Read moreTag: OKN4395
What You Ought to Know: – Owkin, an AI-powered biotech firm, as we speak introduced the ...
Read more